SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001600132-17-000002
Filing Date
2017-01-04
Accepted
2017-01-04 08:37:52
Documents
2
Period of Report
2017-01-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjanuary2017fda.htm 8-K 25757
2 EXHIBIT 99.1 a8-kjanuary2017fdaex991.htm EX-99.1 14251
  Complete submission text file 0001600132-17-000002.txt   41182
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 17503613
SIC: 2834 Pharmaceutical Preparations